Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$8.49−0.21 (-2.41%)
Close on Nov 17, 2026Market cap $1.55BP/E –Yield –
Teladoc Health price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Teladoc Health's price to sales ratio was 0.7× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.4× to 7.9×, with a median of 0.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | +0.2 |
| 2025 | Dec 31, 2025 | 0.5× | −0.1 |
| 2024 | Dec 31, 2024 | 0.6× | −0.8 |
| 2023 | Dec 29, 2023 | 1.4× | −0.3 |
| 2022 | Dec 30, 2022 | 1.7× | −6.2 |
| 2021 | Dec 31, 2021 | 7.9× | −11.6 |
| 2020 | Dec 31, 2020 | 19.5× | +7.8 |
| 2019 | Dec 31, 2019 | 11.7× | +2.3 |
| 2018 | Dec 31, 2018 | 9.3× | −0.9 |
| 2017 | Dec 29, 2017 | 10.2× | +3.2 |
| 2016 | Dec 30, 2016 | 7.0× | −3.2 |
| 2015 | Dec 31, 2015 | 10.2× | – |
See a number that looks wrong?